151 related articles for article (PubMed ID: 37580851)
21. Platypnoea-orthodeoxia syndrome secondary to patent foramen ovale (PFO): a challenging subset for PFO percutaneous closure.
Zavalloni D; Lisignoli V; Barbaro C; Mennuni M; Tosi P; Marcheselli S; Presbitero P
Heart Lung Circ; 2013 Aug; 22(8):642-6. PubMed ID: 23497825
[TBL] [Abstract][Full Text] [Related]
22. Patent Foramen Ovale and Hypoxemia.
Mojadidi MK; Ruiz JC; Chertoff J; Zaman MO; Elgendy IY; Mahmoud AN; Al-Ani M; Elgendy AY; Patel NK; Shantha G; Tobis JM; Meier B
Cardiol Rev; 2019; 27(1):34-40. PubMed ID: 29570476
[TBL] [Abstract][Full Text] [Related]
23. Percutaneous Closure of Patent Foramen Ovale in the Setting of Pulmonary Embolism (Right-Left Shunt Causing Severe Hypoxia).
Johnson J; Kodra A; Basman C; Scheinerman SJ; Patel N; Kliger C
Innovations (Phila); 2020; 15(5):478-480. PubMed ID: 32758050
[TBL] [Abstract][Full Text] [Related]
24. Carcinoid heart disease with right to left shunt across a patent foramen ovale: a case report and review of literature.
Chowdhury MA; Taleb M; Kakroo MA; Tinkel J
Echocardiography; 2015 Jan; 32(1):165-9. PubMed ID: 24976489
[No Abstract] [Full Text] [Related]
25. Patent foramen ovale: anatomy, outcomes, and closure.
Calvert PA; Rana BS; Kydd AC; Shapiro LM
Nat Rev Cardiol; 2011 Mar; 8(3):148-60. PubMed ID: 21283148
[TBL] [Abstract][Full Text] [Related]
26. 4-Valve Heart Disease and Right Heart Failure.
Hollon M; Glas K; Sumler M
J Cardiothorac Vasc Anesth; 2018 Apr; 32(2):838-845. PubMed ID: 29395828
[TBL] [Abstract][Full Text] [Related]
27. Patent foramen ovale closure by using transesophageal echocardiography for cryptogenic stroke: single center experience in 132 consecutive patients.
Han Y; Zhang X; Zhang F
J Cardiothorac Surg; 2020 Jan; 15(1):11. PubMed ID: 31918738
[TBL] [Abstract][Full Text] [Related]
28. Features of carcinoid heart disease identified by 2- and 3-dimensional echocardiography and cardiac MRI.
Bhattacharyya S; Toumpanakis C; Burke M; Taylor AM; Caplin ME; Davar J
Circ Cardiovasc Imaging; 2010 Jan; 3(1):103-11. PubMed ID: 19920029
[TBL] [Abstract][Full Text] [Related]
29. Determinants and clinical significance of persistent residual shunting in patients with percutaneous patent foramen ovale closure devices.
Shafi NA; McKay RG; Kiernan FJ; Silverman IE; Ahlquist M; Silverman DI
Int J Cardiol; 2009 Nov; 137(3):314-6. PubMed ID: 19616327
[TBL] [Abstract][Full Text] [Related]
30. Feasibility of patent foramen ovale closure with no-device left behind: first-in-man percutaneous suture closure.
Ruiz CE; Kipshidze N; Chiam PT; Gogorishvili I
Catheter Cardiovasc Interv; 2008 Jun; 71(7):921-6. PubMed ID: 18412251
[TBL] [Abstract][Full Text] [Related]
31. Carcinoid heart disease with severe hypoxia due to interatrial shunt through patent foramen ovale.
Boglioli LR; Gardiner J; Gerstenblith G; Taff ML; Cameron DE
Tex Heart Inst J; 1997; 24(2):125-8. PubMed ID: 9205988
[TBL] [Abstract][Full Text] [Related]
32. [Patent foramen ovale and hypoxaemia with or without elevated right heart pressures].
Bancal C; Arnoult F; Krapf L; Bonay M
Rev Mal Respir; 2011 Oct; 28(8):967-77. PubMed ID: 22099402
[TBL] [Abstract][Full Text] [Related]
33. Percutaneous closure of a patent foramen ovale in left-sided carcinoid heart disease.
Chaudhari PR; Abergel J; Warner RR; Zacks J; Love BA; Halperin JL; Adler E
Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):455-9. PubMed ID: 17653118
[TBL] [Abstract][Full Text] [Related]
34. Haemodynamic complications after pneumonectomy: atrial inflow obstruction and reopening of the foramen ovale.
Aigner C; Lang G; Taghavi S; Reza-Hoda MA; Marta G; Baumgartner H; Klepetko W
Eur J Cardiothorac Surg; 2008 Feb; 33(2):268-71. PubMed ID: 18061472
[TBL] [Abstract][Full Text] [Related]
35. Percutaneous closure of inter-atrial communications (atrial septal defect and patent foramen ovale): single-centre experience and mid-term follow-up.
Van de Bruaene A; Stroobants D; Benit E
Acta Cardiol; 2015 Apr; 70(2):133-40. PubMed ID: 26148372
[TBL] [Abstract][Full Text] [Related]
36. Incidence and Outcomes of Positive Bubble Contrast Study Results After Transcatheter Closure of a Patent Foramen Ovale.
Shah AH; Osten M; Benson L; Alnasser S; Bach Y; Vishwanath R; Van De Bruaene A; Shulman H; Navaranjan J; Khan R; Horlick E
JACC Cardiovasc Interv; 2018 Jun; 11(11):1095-1104. PubMed ID: 29880106
[TBL] [Abstract][Full Text] [Related]
37. P594Contrast transthoracic echocardiography as a gatekeeper for patent foramen ovale closure.
Muratori M; Italiano G; Innocenti E; Fusini L; Mapelli M; Tamborini G; Ghulam Ali S; Gripari P; Maltagliati A; Celeste F; Pepi M
Eur Heart J Cardiovasc Imaging; 2016 Dec; 17(suppl_2):ii109-ii113. PubMed ID: 28415099
[TBL] [Abstract][Full Text] [Related]
38. Short-term results of percutaneous closure of a patent foramen ovale guided by transoesophageal echocardiography in patients with cryptogenic stroke: a retrospective study.
Guo Y; Shi Z; Zheng Y; Xie C; Yi J; Chen Z; Shu Y; Zhou D
J Cardiothorac Surg; 2022 May; 17(1):96. PubMed ID: 35505434
[TBL] [Abstract][Full Text] [Related]
39. Nonsurgical closure of a patent foramen ovale in a patient with carcinoid heart disease and severe hypoxia from interatrial shunting.
Marenco J; Naimi S; Hijazi Z; Patel A; Pandian N
Catheter Cardiovasc Interv; 2000 Oct; 51(2):210-3. PubMed ID: 11025579
[TBL] [Abstract][Full Text] [Related]
40. Patent Foramen Ovale Closure for Hypoxemia.
Tobis JM; Narasimha D; Abudayyeh I
Interv Cardiol Clin; 2017 Oct; 6(4):547-554. PubMed ID: 28886845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
